local_hospital

Centre de Coordination en Cancérologie François Baclesse

Address
lock Available on a paid plan

Female Urogenital Diseases and Pregnancy Complications

At the Centre de Coordination en Cancérologie François Baclesse in Caen, clinical research in this area focuses on low-risk gestational trophoblastic neoplasia. The trials are designed to assess new treatment approaches and improve care for patients with this rare pregnancy-related cancer.

  • Research on gestational trophoblastic neoplasia and related pregnancy complications
  • Evaluation of a new therapeutic strategy for low-risk disease
  • Clinical work aimed at improving first-line treatment options

This field combines oncology and women’s health, with a focus on finding better ways to treat uncommon conditions while supporting effective early intervention.

Nervous System Diseases

Research in nervous system diseases at this site centers on adult brain stem gliomas, especially non-contrast-enhancing diffuse brainstem gliomas with signs of progression. The studies are exploring whether treatment can better control tumor growth and support patients with this difficult-to-treat brain cancer.

  • Studies in adult brain stem gliomas
  • Focus on diffuse brainstem tumors with clinical or radiological progression
  • Assessment of treatment effectiveness for first-line care

The work reflects a strong interest in neuro-oncology, with the goal of improving outcomes for adults facing aggressive brain tumors.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
0
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
2
Outperforms 44% of sites
public
Therapeutic diversity
2areas
Outperforms 40% of sites
groups
Sponsor diversity
2sponsors
Outperforms 45% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre de Coordination en Cancérologie François Baclesse

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Temozolomide Monotherapy in Adult Patients with Non-Enhancing Diffuse Brainstem Gliomas Exhibiting Infiltrative ProgressionAssistance Publique Hopitaux De ParisPhase IIRecruitingJul 2019

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.